DuPont de Nemours, Inc.

DD NYSE CIK: 0001666700

Company Information

Industry Plastic Materials, Synth Resins & Nonvulcan Elastomers
SIC Code 2821
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 974 CENTRE ROAD, WILMINGTON, DE, 19805
Mailing Address 974 CENTRE ROAD, WILMINGTON, DE, 19805
Phone (302) 295-5783
Fiscal Year End 1231
EIN 811224539

Financial Overview

FY2025

$-0.30
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
8-K Current report of material events March 18, 2026 View on SEC
8-K Current report of material events March 16, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC

Annual Reports

10-K February 17, 2026
  • DuPont has strategically reshaped its business to focus on high-growth, high-margin segments: Healthcare & Water Technologies and Diversified Industrials.
  • Net Income improved to $1.8 billion in 2023 (from $1.5 billion in 2022), and Adjusted EPS rose to $3.95 (from $3.20 in 2022), demonstrating positive portfolio optimization.
View Analysis

Material Events

8-K Strategy Change March 16, 2026
High Impact
  • DuPont is selling its entire Aramids business (including Kevlar® and Nomex®) to Arclin for $1.75 billion in cash.
  • DuPont will retain a 19.9% minority equity interest in the divested business, allowing for future growth participation.
View Analysis

Related Companies

Companies in the same industry (SIC: 2821)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.